#EBW26 Editorial: B Medical Systems supporting quality-driven biobanking and global health
This article has 481 words and is a 2-minute read.
The Europe Biobank Week Congress highlights new developments and addresses key topics in the global biobanking and biomolecular resources field. It serves as a hub for professionals, patients, and government representatives to come together, exchange ideas, and gain valuable insights. Over four days, participants can attend inspiring keynote speeches, join in discussions, network with others and explore exhibits showcasing the latest technologies and products.
We have spoken with all of our sponsors for 2026 to understand why they value being part of the most important in-person event of the year for the global biobanking community. Here’s what B Medical Systems had to say.
Company description
B Medical Systems is a Luxembourg-based manufacturer and global distributor of medical refrigeration devices.
Our mission at B Medical Systems is to create technology that helps save lives across the world. With our four decades of industry experience, we have developed a strong reputation as a customer-centric supplier of medical-grade refrigerators, freezers and transport boxes that deliver the highest performance in terms of safety, efficiency and reliability.
Our portfolio covers a wide range of applications in medical refrigeration, blood management and vaccine cold chain. For the latter, as the market leader in that industry, in the last 20 years, our vaccine cold chain equipment has helped vaccinate more than 300 million children in developing countries. We take pride in these long-lasting relationships with humanitarian leaders such as Health Ministers and NGOs who trust our technology and recognize its reliable performance.
Why does it matter to be at EBW26?
Being part of Europe Biobank Week 2026 matters because it brings together the full spectrum of the biobanking and biomedical research community – scientists, biobank leaders, policymakers and industry innovators – to shape the future of quality-driven, data-empowered health research across Europe and beyond.
For us, EBW26 is an essential platform to: engage directly with the biobanking community, understand emerging needs and contribute to discussions that influence standards and best practices; showcase our solutions that support high-quality biospecimen management, data integrity and research excellence; collaborate with partners and thought leaders who are driving the next generation of precision medicine, translational research and ethical data governance; and stay at the forefront of innovation, discovering new trends, technologies and regulatory developments that shape the future of biobanking.
EBW 2026 offers a unique opportunity to connect, learn and contribute to a community committed to improving research outcomes and advancing global health and we’re proud to be part of it.
What new innovation are you bringing or what are you most looking forward to?
We’re looking forward to connecting with the biobanking community and sharing how our solutions support more efficient, standardised and data‑driven workflows. EBW 2026 is a unique opportunity to exchange insights and explore what’s next for biobanking and biomedical research.